Has systemic clindamycin hydrochloride use during the second and third trimesters of pregnancy been associated with an increased frequency of congenital abnormalities?

In clinical trials with pregnant women, systemic clindamycin hydrochloride use during the second and third trimesters has not been associated with an increased frequency of congenital abnormalities, but it should be used in pregnancy only if clearly needed.